{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:50:26Z","timestamp":1790610626610,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1G1A1099743"],"award-info":[{"award-number":["NRF-2019R1G1A1099743"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI18C2383"],"award-info":[{"award-number":["HI18C2383"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-022-08885-2","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T16:05:41Z","timestamp":1654272341000},"page":"8629-8638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Transient severe motion artifacts on gadoxetic acid\u2013enhanced MRI: risk factor analysis in 2230 patients"],"prefix":"10.1007","volume":"32","author":[{"given":"Eun Bee","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6898-6617","authenticated-orcid":false,"given":"Sang Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Baek","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeyong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousun","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jung","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"8885_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1148\/radiol.10091388","volume":"255","author":"SS Ahn","year":"2010","unstructured":"Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY (2010) Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology 255:459\u2013466","journal-title":"Radiology"},{"key":"8885_CR2","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1148\/radiol.11101840","volume":"261","author":"K Sano","year":"2011","unstructured":"Sano K, Ichikawa T, Motosugi U et al (2011) Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology 261:834\u2013844","journal-title":"Radiology"},{"key":"8885_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1148\/radiol.11101742","volume":"262","author":"L Grazioli","year":"2012","unstructured":"Grazioli L, Bondioni MP, Haradome H et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520\u2013529","journal-title":"Radiology"},{"key":"8885_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1148\/radiol.11103548","volume":"260","author":"U Motosugi","year":"2011","unstructured":"Motosugi U, Ichikawa T, Morisaka H et al (2011) Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology 260:446\u2013453","journal-title":"Radiology"},{"key":"8885_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1148\/radiol.12120826","volume":"266","author":"MS Davenport","year":"2013","unstructured":"Davenport MS, Viglianti BL, Al-Hawary MM et al (2013) Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology 266:452\u2013461","journal-title":"Radiology"},{"key":"8885_CR6","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1007\/s00330-017-5070-y","volume":"28","author":"JS Song","year":"2018","unstructured":"Song JS, Choi EJ, Park EH, Lee JH (2018) Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method. Eur Radiol 28:1132\u20131139","journal-title":"Eur Radiol"},{"key":"8885_CR7","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1007\/s00330-020-07039-6","volume":"30","author":"J Rimola","year":"2020","unstructured":"Rimola J, Darnell A, Belmonte E et al (2020) Does transient arterial-phase respiratory-motion-related artifact impact on diagnostic performance? An intra-patient comparison of extracellular gadolinium versus gadoxetic acid. Eur Radiol 30:6694\u20136701","journal-title":"Eur Radiol"},{"key":"8885_CR8","doi-asserted-by":"publisher","unstructured":"Kim DW, Choi SH, Park T, Kim SY, Lee SS, Byun JH (2021) Transient severe motion artifact on arterial phase in gadoxetic acid-enhanced liver magnetic resonance imaging: a systematic review and meta-analysis. Invest Radiol. https:\/\/doi.org\/10.1097\/rli.0000000000000806","DOI":"10.1097\/rli.0000000000000806"},{"key":"8885_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723\u2013750","journal-title":"Hepatology"},{"key":"8885_CR10","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2214\/AJR.14.13677","volume":"204","author":"SY Kim","year":"2015","unstructured":"Kim SY, Park SH, Wu EH et al (2015) Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses. AJR Am J Roentgenol 204:1220\u20131227","journal-title":"AJR Am J Roentgenol"},{"key":"8885_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1148\/radiol.14140386","volume":"274","author":"MR Bashir","year":"2015","unstructured":"Bashir MR, Castelli P, Davenport MS et al (2015) Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium. Radiology 274:141\u2013148","journal-title":"Radiology"},{"key":"8885_CR12","doi-asserted-by":"publisher","first-page":"796","DOI":"10.2214\/AJR.13.11587","volume":"203","author":"MS Davenport","year":"2014","unstructured":"Davenport MS, Bashir MR, Pietryga JA, Weber JT, Khalatbari S, Hussain HK (2014) Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact. AJR Am J Roentgenol 203:796\u2013802","journal-title":"AJR Am J Roentgenol"},{"key":"8885_CR13","doi-asserted-by":"publisher","first-page":"93.e91","DOI":"10.1016\/j.crad.2016.08.005","volume":"72","author":"A Furlan","year":"2017","unstructured":"Furlan A, Close ON, Borhani AA, Wu YH, Heller MT (2017) Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients. Clin Radiol 72:93.e91\u201393.e96","journal-title":"Clin Radiol"},{"key":"8885_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.mri.2018.06.022","volume":"53","author":"A Kanki","year":"2018","unstructured":"Kanki A, Tamada T, Abe T, Ikenaga H, Yoshida K, Ito K (2018) Relationship between transient severe motion of the liver in gadoxetic acid or iodinated contrast agent-enhanced imaging and arterial oxygen saturation and heart rate changes. Magn Reson Imaging 53:77\u201381","journal-title":"Magn Reson Imaging"},{"key":"8885_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1148\/radiol.2015150642","volume":"279","author":"U Motosugi","year":"2016","unstructured":"Motosugi U, Bannas P, Bookwalter CA, Sano K, Reeder SB (2016) An investigation of transient severe motion related to gadoxetic acid-enhanced MR imaging. Radiology 279:93\u2013102","journal-title":"Radiology"},{"key":"8885_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200887","volume":"13","author":"KI Ringe","year":"2018","unstructured":"Ringe KI, von Falck C, Raatschen HJ, Wacker F, Hinrichs J (2018) Evaluation of transient respiratory motion artifact at gadoxetate disodium-enhanced MRI-influence of different contrast agent application protocols. PLoS One 13:e0200887","journal-title":"PLoS One"},{"key":"8885_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109313","volume":"132","author":"N Vietti Violi","year":"2020","unstructured":"Vietti Violi N, Argiriadi P, Rosen A et al (2020) Gadoxetate disodium-enhanced MRI: assessment of arterial phase artifacts and hepatobiliary uptake in a large series. Eur J Radiol 132:109313","journal-title":"Eur J Radiol"},{"key":"8885_CR18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1055\/s-0043-102940","volume":"189","author":"L Well","year":"2017","unstructured":"Well L, Rausch VH, Adam G, Henes FO, Bannas P (2017) Transient severe motion artifact related to gadoxetate disodium-enhanced liver MRI: frequency and risk evaluation at a German institution. Rofo 189:651\u2013660","journal-title":"Rofo"},{"key":"8885_CR19","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1148\/radiol.2015141646","volume":"276","author":"T Hayashi","year":"2015","unstructured":"Hayashi T, Saitoh S, Tsuji Y et al (2015) Influence of gadoxetate disodium on oxygen saturation and heart rate during dynamic contrast-enhanced MR imaging. Radiology 276:756\u2013765","journal-title":"Radiology"},{"key":"8885_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2003.50016","volume":"124","author":"R Wiesner","year":"2003","unstructured":"Wiesner R, Edwards E, Freeman R et al (2003) Model for End-stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 124:91\u201396","journal-title":"Gastroenterology"},{"key":"8885_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/jhep.2003.50315","volume":"38","author":"KP Moore","year":"2003","unstructured":"Moore KP, Wong F, Gines P et al (2003) The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 38:258\u2013266","journal-title":"Hepatology"},{"key":"8885_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1148\/radiol.13131988","volume":"271","author":"JA Pietryga","year":"2014","unstructured":"Pietryga JA, Burke LM, Marin D, Jaffe TA, Bashir MR (2014) Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. Radiology 271:426\u2013434","journal-title":"Radiology"},{"key":"8885_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1148\/radiol.14132269","volume":"272","author":"MS Davenport","year":"2014","unstructured":"Davenport MS, Caoili EM, Kaza RK, Hussain HK (2014) Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine. Radiology 272:123\u2013131","journal-title":"Radiology"},{"key":"8885_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clinimag.2016.09.004","volume":"41","author":"MR Shah","year":"2017","unstructured":"Shah MR, Flusberg M, Paroder V, Rozenblit AM, Chernyak V (2017) Transient arterial phase respiratory motion-related artifact in MR imaging of the liver: an analysis of four different gadolinium-based contrast agents. Clin Imaging 41:23\u201327","journal-title":"Clin Imaging"},{"key":"8885_CR25","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1164\/ajrccm.164.5.2012122","volume":"164","author":"DE O\u2019Donnell","year":"2001","unstructured":"O\u2019Donnell DE, Revill SM, Webb KA (2001) Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:770\u2013777","journal-title":"Am J Respir Crit Care Med"},{"key":"8885_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1053\/j.gastro.2019.02.049","volume":"157","author":"F Kanwal","year":"2019","unstructured":"Kanwal F, Singal AG (2019) Surveillance for hepatocellular carcinoma: current best practice and future direction. Gastroenterology 157:54\u201364","journal-title":"Gastroenterology"},{"key":"8885_CR27","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1007\/s00330-015-4086-4","volume":"26","author":"A Gutzeit","year":"2016","unstructured":"Gutzeit A, Matoori S, Froehlich JM et al (2016) Reduction in respiratory motion artefacts on gadoxetate-enhanced MRI after training technicians to apply a simple and more patient-adapted breathing command. Eur Radiol 26:2714\u20132722","journal-title":"Eur Radiol"},{"key":"8885_CR28","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1007\/s00330-018-5307-4","volume":"28","author":"JH Min","year":"2018","unstructured":"Min JH, Kim YK, Kang TW et al (2018) Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging. Eur Radiol 28:3335\u20133346","journal-title":"Eur Radiol"},{"key":"8885_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11604-019-00896-2","volume":"38","author":"H Ikeno","year":"2020","unstructured":"Ikeno H, Kobayashi S, Kozaka K et al (2020) Relationship between the degree of abdominal wall movement and the image quality of contrast-enhanced MRI: semi-quantitative study especially focused on the occurrence of transient severe motion artifact. Jpn J Radiol 38:165\u2013177","journal-title":"Jpn J Radiol"},{"key":"8885_CR30","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1007\/s00330-015-3736-x","volume":"25","author":"JA Luetkens","year":"2015","unstructured":"Luetkens JA, Kupczyk PA, Doerner J et al (2015) Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol. Eur Radiol 25:3207\u20133213","journal-title":"Eur Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-08885-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-022-08885-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-08885-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T16:05:45Z","timestamp":1669651545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-022-08885-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8885"],"URL":"https:\/\/doi.org\/10.1007\/s00330-022-08885-2","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"13 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Sang Hyun Choi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"Sang Hyun Choi declares relationships with the following companies: Bayer Healthcare. The other authors of this manuscript have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}